IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
286.66M
MIST
Price
$0.77
Change
+$0.02 (+2.67%)
Updated
Apr 11 closing price
Capitalization
41.15M
35 days until earnings call
Ad is loading...

IVEVF vs MIST

Header iconIVEVF vs MIST Comparison
Open Charts IVEVF vs MISTBanner chart's image
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization286.66M
Milestone Pharmaceuticals
Price$0.77
Change+$0.02 (+2.67%)
Volume$1.04M
Capitalization41.15M
IVEVF vs MIST Comparison Chart
Loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVEVF vs. MIST commentary
Apr 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVEVF is a Buy and MIST is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 14, 2025
Stock price -- (IVEVF: $2.28 vs. MIST: $0.77)
Brand notoriety: IVEVF and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVEVF: 109% vs. MIST: 37%
Market capitalization -- IVEVF: $286.66M vs. MIST: $41.15M
IVEVF [@Biotechnology] is valued at $286.66M. MIST’s [@Biotechnology] market capitalization is $41.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVEVF’s FA Score shows that 0 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • IVEVF’s FA Score: 0 green, 5 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, IVEVF is a better buy in the long-term than MIST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 4 TA indicator(s) are bullish.

  • MIST’s TA Score: 4 bullish, 5 bearish.

Price Growth

IVEVF (@Biotechnology) experienced а 0.00% price change this week, while MIST (@Biotechnology) price change was +10.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

MIST is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVEVF($287M) has a higher market cap than MIST($41.2M). IVEVF YTD gains are higher at: -37.363 vs. MIST (-67.318).
IVEVFMISTIVEVF / MIST
Capitalization287M41.2M697%
EBITDAN/A-37.83M-
Gain YTD-37.363-67.31856%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A69.7M-
Total DebtN/A54.8M-
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MIST
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMRX1.290.05
+4.03%
Immuneering Corp
ENB43.241.42
+3.40%
Enbridge
NSSC21.590.58
+2.76%
NAPCO Security Technologies
CSAN4.780.10
+2.14%
Cosan SA
JILL16.22-0.22
-1.34%
JJill

IVEVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with VERV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
VERV - IVEVF
46%
Loosely correlated
+6.89%
DTIL - IVEVF
32%
Poorly correlated
+4.02%
MIST - IVEVF
28%
Poorly correlated
+2.84%
AWKNF - IVEVF
25%
Poorly correlated
N/A
IDRSF - IVEVF
21%
Poorly correlated
N/A
More